EMEA-000245-PIP01-08-M04

Key facts

Invented name
Amitiza
Active substance
Lubiprostone
Therapeutic area
Gastroentology-Hepatology
Decision number
P/0353/2017
PIP number
EMEA-000245-PIP01-08-M04
Pharmaceutical form(s)
  • Capsule, soft
  • Age-appropriate liquid dosage form
Condition(s) / indication(s)
Treatment of constipation
Route(s) of administration
Oral use
Contact for public enquiries
Sucampo AG
Tel. +41 417263045
E-mail: hschulze@sucampo.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating